Companies

Abilita Bio’s mission is to discover and develop transformative therapeutics by enabling
Discovery and synthesis of a large portfolio of small molecules that prevent the ability
Alumni
Arcturus is poised to become an industry leader in RNAi technologies for the treatment of
Belite Bio is a biotechnology company that specializes in new drug development for
Biosortia Pharmaceuticals is a biopharmaceutical company focused on the development of
Developing, RUC-4, a novel small molecule inhibitor of the platelet αIIbβ3 receptor,
Alumni
Harnessing Childhood Immune Memory to Fight Cancer CHIME BioTherapeutics, Inc. is an
Dermala Inc is utilizing the human microbiome to develop the next generation of
Digital Proteomics is developing a platform for rapid discovery of antibodies directly
Ensysce is improving drug efficacy and safety through two unique platforms. These
Alumni
Forge Therapeutics, Inc is an early stage biotechnology company discovering and developing
Alumni
Jecure Therapeutics' objective is to identify novel drugs for the treatment of fatty liver
Alumni
Lectenz Bio (fka Glycosensors & Diagnostics) is commercializing enabling technologies for
Alumni
Meditope Biosciences is revolutionizing the use of monoclonal antibodies. Our proprietary
Alumni
Siragen is a privately held biopharmaceutical company committed to accelerate clinical